Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-050720
Filing Date
2021-08-10
Accepted
2021-08-10 20:00:21
Documents
1
Period of Report
2021-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11141
  Complete submission text file 0001209191-21-050720.txt   12787
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22 BRIDGEWATER NJ 08807
Business Address
Mikhail Karim (Reporting) CIK: 0001875266 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 211161598